Seasonal allergic or perennial rhinitisAdult (including older patient) & childn ≥12 yr 2 actuations (50 mcg/actuation) in each nostril once daily. Once symptoms are controlled, reduce dose to 1 actuation in each nostril (100 mcg/day). Max daily dose: 4 actuations in each nostril once daily (400 mcg/day). Childn 2-11 yr 1 actuation (50 mcg/actuation). Nasal polyp 2 actuations (50 mcg/actuation) in each nostril once daily. May be increased to a total daily dose of 2 sprays in each nostril bid (400 mcg/day) if symptoms are inadequately controlled after 5-6 wk.
Patients w/ active or quiescent tuberculous infections of the resp tract, or in untreated fungal, bacterial, or systemic viral infections. Risk of exposure to certain infections (e.g., chickenpox, measles) in patients receiving corticosteroids who are potentially immunosuppressed. Examine periodically for possible changes in the nasal mucosa in patients using over several mth or longer. Discontinue if localised fungal infection of the nose or pharynx develops. Not recommended in case of nasal septum perforation. Systemic effects of corticosteroids (high doses in prolonged periods). Increased IOP. Visual disturbance. Patients transferred from long-term administration of systemically active corticosteroids to mometasone furoate aqueous nasal spray. Regularly monitor the height of childn receiving prolonged treatment w/ nasal corticosteroids. Pregnancy & lactation.
Sign Out
